Emerging biotech Taueret Laboratories is a small-to-mid sized biotech research firm in Salt Lake City with a recent history of collaboration and asset divestment, indicating potential openness to strategic partnerships, licensing, or joint development opportunities with larger biomedical organizations.

Strategic collaborations Recent news shows partnerships and joint work related to gene activation studies and endometriosis testing (ARTguide), suggesting a selling point for tools, assays, or contract research services aligned with genomic and diagnostic development.

Asset divestment Assets were sold to Predictive Technology Group in 2018, which may indicate a transition phase or a preference for collaborating through broader platforms; sales outreach could focus on licensing, technology transfer, or exploring synergies with holding or incubator networks.

Limited revenue Reported revenue is under one million dollars, implying a potential need for cost-effective research support, scalable CRO-style services, or targeted pilot projects to demonstrate value and unlock larger engagements.

Tech and analytics Presence of a modern web tech stack and usage of analytics tools suggests readiness for data-driven collaborations; propose data management, bioinformatics, and digital assay workflows as value-add services to improve research efficiency.